Bottom line
XSMO vs OMFS: the short answer
XSMO (Invesco S&P SmallCap Momentum ETF) and OMFS (Invesco Russell 2000(R) Dynamic Multifactor ETF) are both etfs.
But OMFS is far broader, holding 1,107 positions to 110 for XSMO, so beyond the top names it adds exposure XSMO doesn't have.
XSMO is cheaper at 0.35% vs 0.39% — a difference of $4.00 a year per $10,000 invested.
Over five years, XSMO returned +9.6% a year vs +7.9% for OMFS (reporting dates differ).
Updated Nov 19, 2026
XSMO vs OMFS side by side
| XSMO | OMFS | |
|---|---|---|
| Type | ETF | ETF |
| Fund family | Invesco | Invesco |
| Category | Small-Cap | Small-Cap |
| Expense ratio | 0.35% | 0.39% |
| Annual cost per $10k | $35 | $39 |
| 10-yr cost on $10k (prospectus) | $444 | $493 |
| Max front load | None | None |
| 12b-1 fee | — | — |
| 1-yr return | +9.8% | +4.0% |
| 5-yr return (annualized) | +9.6% | +7.9% |
| 10-yr return (annualized) | +12.3% | — |
| Best quarter | +23.7% | +38.8% |
| Worst quarter | −25.2% | −33.2% |
| Net assets (fund) | $3.0B | $283.3M |
| Number of holdings | 110 | 1,107 |
| Portfolio turnover | 121% | 65% |
| Returns as of | Dec 31, 2025 | Dec 31, 2024 |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | XSMO | OMFS | Difference |
|---|---|---|---|
| 2024 | +17.6% | +4.0% | +13.6% |
| 2023 | +21.4% | +15.3% | +6.2% |
| 2022 | −15.5% | −17.3% | +1.8% |
| 2021 | +19.3% | +28.8% | −9.5% |
| 2020 | +21.8% | +14.7% | +7.2% |
| 2019 | +28.3% | +27.0% | +1.3% |
| 2018 | −2.9% | −8.4% | +5.5% |
Source: Fund prospectus bar charts
Holdings overlap
5 of XSMO's top 25 holdings also appear in OMFS's top 25.
| Holding | XSMO | OMFS |
|---|---|---|
| Invesco Private Prime Fund | 11.81% | 23.92% |
| Invesco Private Government Fund | 4.51% | 9.21% |
| Protagonist Therapeutics, Inc. | 2.57% | 0.87% |
| Indivior Pharmaceuticals, Inc. | 2.20% | 1.81% |
| FormFactor, Inc. | 1.98% | 0.65% |
Source: SEC Form N-PORT
XSMO top 10
- Invesco Private Prime Fund — 11.81%
- Viasat, Inc. — 4.59%
- Invesco Private Government Fund — 4.51%
- ESCO Technologies Inc. — 2.97%
- Protagonist Therapeutics, Inc. — 2.57%
- Indivior Pharmaceuticals, Inc. — 2.20%
- Mercury Systems, Inc. — 2.17%
- StoneX Group Inc. — 2.17%
- FormFactor, Inc. — 1.98%
- Ligand Pharmaceuticals Inc. — 1.88%
OMFS top 10
- Invesco Private Prime Fund — 23.92%
- Invesco Private Government Fund — 9.21%
- Nextpower Inc. — 1.96%
- Sterling Infrastructure, Inc. — 1.86%
- Indivior Pharmaceuticals, Inc. — 1.81%
- Argan, Inc. — 1.57%
- Planet Labs PBC — 1.56%
- Arrowhead Pharmaceuticals, Inc. — 1.41%
- Rambus Inc. — 1.34%
- CareTrust REIT, Inc. — 1.21%
FAQ
What is the difference between XSMO and OMFS?
Which is cheaper, XSMO or OMFS?
Should I own both XSMO and OMFS?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.